Жданов В.М., Гайдамович С.Я. Общая и частная вирусология. М.: Медицина, 1982. В 2-х т.
Баринский И.Ф. Семейство герпес вирусов // Общая и частная вирусология. –М., 1982. С. 375–412.
Самгин М.А., Халдин А.А. Простой герпес: дерматологические аспекты М. МЕДпресс-информ, 2002 159 с.
Баринский И.Ф., Шубладзе А.К., Каспаров А.А., Гребенюк В.Н. Герпес: Этиология, диагностика и лечение. М.: Медицина, 1986. 268 с.
Куханова М.К., Коровина А.Н., Кочетков С.Н. Вирус простого герпеса человека: жизненный цикл и поиск ингибитора. Успехи биологической химии. 2014; 54: С. 457 - 494.
Бикбулатов Р.М., Демидова С.А., Бочаров Л.Ф. и др. Факторы гуморального иммунитета в патогенезе хронической герпетической инфекции // Вопр.вирусол. 1982. Т. 27. –№3. С. 67–71.
Ashley R., Benedetti J., Corey L. Humoral immune response to HSV-1 and HSV-2viral proteins in patients with primary genital herpes // J. med. Virol. 1985. –Vol. 17. №2. P. 153–166.
Feldman M., Howell D., Fitzgeraid#Bocarsly P. Interferon-alpha-depended and independent participation of accessory cells in natural killer cell-mediated lysisof HSV-1-infected fibroblasts // J. Leukoc. Biol. 1992. Vol. 52. №5. –P. 473–482.
Сухих Г.Т., Ванько Л.В., Кулаков В.И. Иммунитет и генитальный герпес. –Н. Новгород, 1997. 220 с.
Gill N., Chenoweth M.J., Verdu E.F., Ashkar A.A. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection. Cell. Immunol. 2011; 269 (1): P. 29 - 37.
Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008; 86: P. 805 - 812.
Hashido M., Lee F.K., Nahmias A.J. et al. An epidemiologic study of herpes simplex virus types 1 and 2 infection in Japan based on type-specific serological assays //Epidemiol. Infect. 1998. №120. Р. 179–186.
Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35: S173. (http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of- genital-herpes-simplex-virus-infection/abstract/73)
Ресурсы и деятельность медицинских организаций дерматовенерологического профиля, заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2017-2018 годы (статистические материалы). Москва. 29019. 208 с. РИО: ФГБУ «ЦНИИОИЗ» Минздрава России.
Patel R., Alderson S., Geretti A. et al. IUSTI/WHO Europe. European guideline for the management of genital herpes. Int. J. STD AIDS. 2011; 22 (1): P. 1 - 10.
Gupta R., Warren T., Wald A. Genital herpes. Lancet. 2007; 370 (9605): P. 2127 - 2137.
Beauman J.G. Genital herpes: a review. Am Fam Physician 2005; 72: 1527 - 1534.
Wald A, Huang M-L, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003; 188: 1345–3151.
van Doornum GJ, Guldemeester J, Osterhaus AD, et al. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41: 576–580.
Geretti AM. Genital herpes. Sex Transm Infect 2006; 82: iv31–iv34.
Munday PE, Vuddamalay J, Slomka MJ, et al. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect 1998; 74: 175–178.
Ashley RL and Wald A. Genital herpes: review of the epidemic and potential use of type- specific serology. Clin Microbiol Rev 1999; 12: 1–8.
Malkin JE. Herpes simplex virus: who should be tested? Herpes 2002; 9: 31.
Copas AJ, Cowan FM, Cunningham AL, et al. An evidence based approach to testing for antibody to herpes simplex virus type 2. Sex Transm Infect 2002; 78: 430–434.
LeGoff J, Péré H, Bélec L. Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virol J. 2014 May 12;11:83. doi: 10.1186/1743-422X-11-83.
Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes. 2002 Jul;9(2):38-45.
Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509–515.
Rouse DJ and Stringer JS. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000; 183: 400 406.
Tita AT, Grobman WA and Rouse DJ. Antenatal herpes serologic screening: an appraisal of the evidence. Obstet Gynecol 2006; 108: 1247–1253.
Raj Patel, John Green, Emily Clarke et al. 2014 UK national guideline for the management of anogenital herpes. Int J STD AIDS. 2015 Oct;26(11):763-76. doi: 10.1177/0956462415580512. Epub 2015 Apr 9.
Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002; 9: 38–45.
Smith JS, Bailey RC, Westreich DJ, et al. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon, ELISA, Western blot and inhibition testing. Sex Transm Infect 2009; 85: 92–96.
Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods 2000; 87: 71–80.
Bollen LJ, Whitehead SJ, Mock PA, et al. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission? AIDS 2008; 22: 1169–1176.
Chen KT, Tuomala RE, Chu C, et al. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol 2008; 198: 399 e1–e5.
Ashley R. Type-specific antibodies to HSV-1 and-2: review of methodology. Herpes 1998; 5: 33–38.